Search research articles
Contact Us
Filters
Showing results (141-150 of 144) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 144 results.
Irish Journal of Medical Science
|
August 13, 2005
Autologous stem cell transplantation in myeloma: the St James's Hospital experience, 1997-2003
P J Hayden, A O'Driscoll, N Gardiner, et al.
Alcohol (Fayetteville, N.Y.)
|
April 6, 2024
Emerging concepts in alcohol, infection & immunity: A summary of the 2023 alcohol and immunology research interest group (AIRIG) meeting
Lauren N Rutt, Mengfei Liu, Esther Melamed, et al.
Journal of Cardiovascular Development and Disease
|
November 26, 2025
Cardiomyocyte Nuclear Pleomorphism in a Mouse Model of Inherited Hypertrophic Cardiomyopathy
Jamie R Johnston, Isabella Leite Coscarella, Carson L Rose, et al.
American Journal of Hematology
|
February 8, 2022
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma
Peter O'Gorman, Jacob P Laubach, Michael E O'Dwyer, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 144) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 144 results.
Irish Journal of Medical Science
|
August 13, 2005
Autologous stem cell transplantation in myeloma: the St James's Hospital experience, 1997-2003
P J Hayden, A O'Driscoll, N Gardiner, et al.
Alcohol (Fayetteville, N.Y.)
|
April 6, 2024
Emerging concepts in alcohol, infection & immunity: A summary of the 2023 alcohol and immunology research interest group (AIRIG) meeting
Lauren N Rutt, Mengfei Liu, Esther Melamed, et al.
Journal of Cardiovascular Development and Disease
|
November 26, 2025
Cardiomyocyte Nuclear Pleomorphism in a Mouse Model of Inherited Hypertrophic Cardiomyopathy
Jamie R Johnston, Isabella Leite Coscarella, Carson L Rose, et al.
American Journal of Hematology
|
February 8, 2022
Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma
Peter O'Gorman, Jacob P Laubach, Michael E O'Dwyer, et al.
Page
of 15